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ABSTRACT Using a coarse-grained model of the Ab peptide, we analyze the Arctic (E22G), Dutch (E22Q), and Flemish
(A21G) familial Alzheimer’s disease (FAD) mutants for any changes in the stability of amyloid assemblies with respect to the
wild-type (WT) sequence. Based on a structural reference state of two protoﬁlaments aligned to create the ‘‘agitated’’ protoﬁbril
as determined by solid-state NMR, we determine free energy trends for Ab assemblies for the WT and FAD familial sequences.
We ﬁnd that the structural characteristics and oligomer size of the critical nucleus vary dramatically among the hereditary
mutants. The Arctic mutant’s disorder in the turn region introduces new stabilizing interactions that better align the two
protoﬁlaments, yielding a well-deﬁned protoﬁbril axis at relatively small oligomer sizes with respect to WT. By contrast, the
critical nucleus for the Flemish mutant is beyond the 20 chains characterized in this study, thereby showing a strong shift in the
equilibrium toward monomers with respect to larger protoﬁbril assemblies. The Dutch mutant forms more ordered protoﬁlaments
than WT, but exhibits greater disorder in protoﬁbril structure that includes an alternative polymorph of the WT ﬁbril. An important
conclusion of this work is that the Dutch mutant does not support the agitated protoﬁbril assembly. We discuss the implications
of the structural ensembles and free energy proﬁles for the FAD mutants in regards to interpretation of the kinetics of ﬁbril
assembly using chromatography and dye-binding experiments.
INTRODUCTION
Alzheimer’s disease (AD) is characterized by the appearance
of neuritic plaque deposits comprised primarily of amyloid b
peptide (1), whose chemicophysical properties are central to
understanding the disease state. Amyloid b is created by
proteolytic cleavage of the amyloid precursor protein (APP),
as a 40 or more virulent 42 residue sequence (Ab1–40 or Ab1–
42) with unknown function (1,2). Although many familial
Alzheimer’s disease (FAD) mutants of the APP protein are
external to the Ab peptide sequence and typically inﬂuence
Ab processing, a set of mutants that cluster near amino acid
positions 21 through 23 in the amyloid b peptide itself have
drawn special attention due to possible changes of peptide
biochemistry (1). Some of the most well-studied FAD mu-
tants of amyloid b include the Dutch (E22Q) (3,4), Flemish
(A21G) (5,6), Italian (E22K) (7,8), Arctic (E22G) (9), Iowa
(D23N) (10), and double Dutch/Iowa mutants (E22Q, D23N)
(10), all of which have been characterized for both Ab1–40
and Ab1–42 both in vitro and in vivo. Despite the locality of
the mutation, the FAD mutants show dramatic diversity in
presence or absence of AD dementia symptoms and intra-
cerebral hemorrhaging (10), exhibit variations in Ab1–42
levels in media from cells transfected with a given mutant (9),
and show strong differences in the regions of the brain tissue
or vasculature in which amyloid plaques are deposited (9,11).
More relevant to this study are the strong differences in the
kinetics of the formation of ﬁbril assemblies of WT and
mutant Ab that make up the amyloid plaque (12–15). In vitro
studies have found that the Dutch mutant nucleates and ﬁ-
brillizes more readily than WT, that the Arctic mutation has a
higher propensity to form protoﬁbrils (either distinct from, or
precursors to, the ﬁbril state) although ﬁbrillization rates are
comparable to WT, whereas the rate of ﬁbril formation is
greatly reduced for the Flemish mutant relative to WT (9).
Morelli et al. showed that proteolytic enzymes more easily
degrade monomeric WT Ab, Italian, and Flemish mutants,
whereas proteolysis of the Arctic and Dutch mutant protein is
not as efﬁcient-likely due to their rapid sequestration into
protoﬁbril or ﬁbril morphologies that inhibit degradation by
the enzyme (16). Although in vitro experiments have shown
that different polymorphs of the mature Ab ﬁbril can con-
tribute to variation in cell viability (17), and synaptic activity
is greatly impaired in the presence of the insoluble plaque
(18), biochemical evidence is accumulating that immature
and/or soluble oligomer states may be the more prevalent
cytotoxic species (19–23). Again, the FAD mutants show
distinct differences; cognitive deﬁcits arising from the Arctic
mutant were traced to a nonﬁbrillar form of the Ab peptide,
whereas the severity of memory loss symptoms for carriers of
the Dutch mutation were consistent with interference from
the mature ﬁbrillar Ab species (24).
A convenient separation of the soluble oligomers and
mature ﬁbril regimes may be gleaned from the mechanism of
ﬁbrillization of full length WT Ab peptides that has been
shown to follow a nucleation-dependent polymerization
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mechanism (13,25–27). The kinetic model developed by
Ferrone (28) assumes that the observed lag phase is due to the
formation of a critical nucleus—the assembly of monomers
into a certain oligomer size corresponding to the largest free
energy barrier—beyond which a gradient of favorable free
energy or ‘‘downhill’’ polymerization progresses into a
mature ﬁbril. However, the structural characteristics and ol-
igomer size of the soluble nucleating species have yet to be
determined experimentally for either the WT or familial
mutants, and the mechanism of polymerization that eventu-
ally delineates a mature ﬁbril is unclear.
A number of important computational studies have ad-
dressed the monomer conformation and oligomers assem-
blies of the WT and FAD mutants, both on the full length
sequence as well as Ab fragments (29–43). We have chosen
in this study to focus on the Ab1–40 peptide because the best
quality experimental structural data is available for this sys-
tem (17,44–46). Given the ability of Ab1–42 and Ab1–40 to
cross seed ﬁbril growth, we believe the Ab1–40 structure is
relevant to the ﬁbril form of Ab1–42.
We have recently developed (47) and used a coarse-grained
protein model to characterize the critical nucleus, structural
stability, and ﬁbril elongation propensity of WT Ab1–40
protoﬁbrils (48).We pursue a coarse-grained Camodel unlike
previous all-atom studies because these models enable us to
retain physico–chemical interactions through model physics
faithful to the true system while enabling a full statistical
characterization of the ensemble properties for each mutant,
something not attainable for much more computationally
expensive all atom models. These coarse-grained models
capture both sequence speciﬁc interactions and geometrically
accuratea-helical andb-sheet secondary structure geometries
while retaining the simplicity of a Ca protein model (see
Methods). By careful parameterization of the interaction po-
tentials between coarse grained amino acid positions, these
models capture well the excluded volume and hydrophobic
interactions of the true system. The inclusion of a direction
dependent backbone hydrogen bond potential enables the
model to capture cooperative assembly of secondary struc-
tures with faithful b-sheet geometry resulting in native state
RMSD of;3 A˚ for globular proteins relative to experimental
NMR structures (47). Although favorable opposite charge
interactions can be modeled as attractive interactions, this
model is limited by the lack of explicit electrostatic interac-
tions andwe leave the analysis of speciﬁc charged interactions
to future studies with an enhancedmodel.We have previously
characterized thismodel for theWTsequence and carry out all
analysis of mutants as comparisons to this sequence. Within
our model we have represented two different quaternary
symmetry forms proposed by solid state NMR for so-called
‘‘agitated’’ ﬁbrils (17,44–46). As shown in Fig. 1, the cross
section of the ﬁbril is made up of two ‘‘U-shaped’’ monomers
with hydrophobic C-terminal regions in van der Waals con-
tact in a pseudo-symmetry C2z form, and larger (proto)ﬁbril
peptide assemblies propagate this dimer motif down the ﬁbril
axis. Our nomenclature is to deﬁne a (proto)ﬁbril as being
composed of two (proto)ﬁlaments of in-register parallel in-
termolecular N-terminal and C-terminal b-sheet regions that
can be organized by the C2 symmetry operation about the ﬁ-
bril z axis (Fig. 1). Protoﬁbril refers to a ﬁbril that iswell below
micron-size lengths.
Given this model, we calculated equilibrium populations
of structurally stable and unstable protoﬁbrils for WT Ab1–40
as a function of the number of dimer cross sections, and
evaluated a free energy proﬁle for monomer-protoﬁbril
equilibrium (48). We determined a critical nucleus of 10
chains for WT Ab1–40, characterized as having well formed
intermolecular b-sheets, but lacking structural integrity at the
C-terminal interface so that the protoﬁlaments do not align
along the ﬁbril axis (48). Beyond the critical nucleus, we
found that 16 monomer chains showed the ﬁbril extension
propensities of a mature ﬁbril, for the reason that a sufﬁcient
hydrophobic density is reached to stabilize the C-terminal
interface and therefore align the protoﬁlaments along the ﬁ-
bril axis. At this length, the DDG for cross-section addition is
a constant and deﬁnes polymerization equilibrium as shifted
strongly in favor of the ﬁbril form. Thus the oligomer size
below or above 10 chains for WT Ab delineate the concen-
tration conditions for further study as to whether the cyto-
toxic species correspond to early soluble aggregates or
mature insoluble (proto)ﬁbrils (48).
In this work, we extend our coarse-grained model study of
amyloid assemblies of WT Ab to the Dutch, Flemish, and
Arctic FAD mutants. Our work starts with the assumption
that the best experimental model of the complete WT Ab1–40
amyloid ﬁbril, derived from ﬁbrils prepared under ‘‘agi-
tated’’ conditions (17,44–46), is also an appropriate struc-
tural model of these FAD mutants. An important component
of this work is to test whether the agitated ﬁbril morphology
is an appropriate model for mutations at positions 21 and 22.
Given the importance of the salt bridge deﬁned by D23 and
K28 in stabilizing the agitated ﬁbril assemblies, the Italian
and Iowa FADmutations at position 23 that lose the ability to
FIGURE 1 Ideal cross section of agitated ﬁbril morphology. The two
monomer cross section of the bead model with C2z symmetry based on SS-
NMR data (17, 31–33) after equilibration within a large WT ﬁbril (40-
chain). Ala 21, site of the Flemish mutation, is pictured in orange on one
monomer. Glu-22, site of Arctic and Dutch mutations, is pictured in red.
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neutralize charge will be unlikely to conform to the reported
SS-NMR agitated structure (46), and are not considered in this
study but have been examined recently by Zheng et al. (43).
We ﬁnd that the free energy trends for Ab assemblies
among the familial and WT sequences show that the struc-
tural characteristics and size of the critical nucleus shifts
dramatically among the mutants, even though the single point
mutations are localized in the same region of the Ab peptide.
The Arctic mutant’s disorder in the turn region introduces
new stabilizing interactions that better align the two proto-
ﬁlaments to yield a well-deﬁned ﬁbril axis. By contrast, we
ﬁnd that the critical nucleus for the Flemish mutant is beyond
the 20 chains characterized in this study, thereby indicating a
strong shift in the equilibrium toward monomers with respect
to larger ordered protoﬁbril assemblies. We ﬁnd that the
Dutch mutant forms more ordered protoﬁlaments than WT,
but more disorder in protoﬁbril structure that includes an
alternative polymorph of the WT ﬁbril. We discuss the im-
plications of the structural ensembles and free energy proﬁles
for the FAD mutants in regards to interpretation of the ki-
netics of ﬁbril assembly using chromatography and dye-
binding experiments (9,49).
METHODS
Coarse-grained protein model
The coarse-grained model we developed has been used to study the folding
and aggregation properties of members of the ubiquitin a/b fold class (50–
55), andwe have updated it recently to improve its faithfulness to real proteins
while retaining its simplicity (47). The coarse-grained model consists of an
unbranched chain of beads, each representing a single amino acid. Beads are
assigned interaction type and strength using a Lennard-Jones functional form
based on a mapping from the 20 amino acids to our four bead types: B, strong
attraction; V, weak attraction; N, weak repulsion; and L, strong repulsion.
Interactions between beads three or more positions apart are represented by
potentials of mean force corresponding to bead ﬂavor, and solvation water is
treated implicitly by incorporating favorable interactions between hydro-
phobic groups. Bonds between beads are kept rigid at one reduced distance
unit (;3.8 A˚) representing the distance between Ca positions in a peptide
chain. Angles formed by three consecutive beads are represented by a har-
monic potential with mean 105, the average of the Ca pseudo bond-angle in
extended and helical secondary structures. A single torsional potential, ‘‘S’’,
which has competing minima for helical (;60) and b-sheet (;180) ar-
rangements is applied for every dihedral angles formed by four consecutive
beads with the exception of some of the dihedral angles where one of the
central beads is a glycine in the 20 amino acid sequence. For these dihedrals,
we replace the helical/extended torsional potential with a ‘‘ﬂoppy’’ potential,
‘‘T’’, where the barriers to transition between helical and extended type an-
gles are reduced, in thisway capturing the greater conformational ﬂexibility of
the peptide chain near glycine residues. We have used this model to differ-
entiate sequence driven folding mechanisms of proteins L and G with;3 A˚
RMSD models to the native PDB structures (47), as well as determine the
critical nucleus and ﬁbril elongation propensity of the wild-type Ab1–40 ﬁ-
brils.We refer the reader to our recentwork (47,48) for full speciﬁcation of the
model applicable to this study.
A model of an amyloid dimer cross section was constructed in the single-
bead representation of our model according to the constraints speciﬁed by
Petkova et al. (45). Because this model is a single-bead representation of a
protein, the (f,c) angle constraints were converted into local secondary
structure assignments and then applied to the model. The resulting 20-letter
sequence of the WT Ab1–40 peptide and the corresponding coarse-grained
(CG) primary and secondary structure are:
1sequence DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV
1sequence (CG) LVLBLNLNNBLVNNLNBVBBVLLVNNLNNVBBNBBVNNVV
2structure (CG) SSSSSSSSSSSSSSSSSSSSSSTTSSTTSSSSSSSTT.
We highlight in bold what aspects of the model change under the Arctic
(E22G) or Flemish (A21G) mutations. The amino acid sequence and sec-
ondary structure assignment for our model of the Flemish Ab peptide
(A21G) is
1sequence DAEFRHDSGYEVHHQKLVFFGEDVGSNKGAIIGLMVGGVV
1sequence (CG) LVLBLNLNNBLVNNLNBVBBNLLVNNLNNVBBNBBVNNVV
2structure (CG) SSSSSSSSSSSSSSSSSSTTSSTTSSTTSSSSSSSTT
that changes a bead with small attraction to one of small repulsion, while
making the dihedral angles in that vicinity of the chain ﬂoppier given the
greater conformational ﬂexibility of the glycine backbone. Correspondingly,
the amino acid sequence and secondary structure assignment of the Arctic
Ab peptide (E22G) is:
1sequence DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV
1sequence (CG) LVLBLNLNNBLVNNLNBVBBVNLVNNLNNVBBNBBVNNVV
2structure (CG) SSSSSSSSSSSSSSSSSSSTTSTTSSTTSSSSSSSTT.
This also makes the dihedral angles ﬂoppier, but in a region of the chain
shifted by one amino acid, while at the same time changing a more strongly
repulsive bead interaction to a weaker one. Finally, because the Dutch Ab
peptide mutation (E22Q) does not involve a mutation to glycine, the gluta-
mine mutation is represented only at the level of a primary sequence
1sequence DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV
1sequence (CG) LVLBLNLNNBLVNNLNBVBBVVLVNNLNNVBBNBBVNNVV
2structure (CG) SSSSSSSSSSSSSSSSSSSSSSTTSSTTSSSSSSSTT
in which an L bead that describes repulsion due to the alignment of nega-
tive charge down each of the protoﬁlaments is changed to a V bead that
qualitatively makes the interactions attractive. We justify this change from L
bead to attractive V to represent E22Q by noting that glutamine-glutamine
interactions of this geometry are favorable in polyglutamine aggregates (56).
Globular proteins that contain a sequence run of glutamines are known to
form b-sheets that are stabilized by hydrogen bonds between carbonyl and
amide moieties of the glutamine side chain chemistry as well as hydrophobic
interactions between aligned nonpolar regions of the glutamine side chains,
and polyglutamine ﬁbrils show similar hydrogen bonding patterns that
stabilize the intermolecular assemblies (56).
These three mutations, Flemish, Arctic, and Dutch have clear coarse-
grained bead and dihedral mutations that we have described above. Repre-
senting change of charge mutations from acidic to basic amino acids such as
the Italian mutation (E22K) are difﬁcult to represent in our current formula-
tion of the coarse-grained model that does not include explicit treatment of
electrostatic effects. We believe that the mutations we have pursued here
capture the type of change that would be seen in the full atomistic system
because the perturbation of theWT system, towhichwe always compare in its
coarse-grained form, is well represented by the mutations. We note that the
Artic and Dutch mutations do result in a change in the charge of the peptide
that undoubtedly inﬂuences monomer and disordered oligomer thermody-
namics and dimerization kinetics in a pH and salt dependent manner. Our
study, however, aims to examine how these mutations, local changes to the
sequence represented well by bead and backbone dihedral angle differences,
affect the global structure and thermodynamics of the protoﬁbril and ﬁbril
assemblies in standard physiological buffer conditions for which our original
model has been parameterized.
Model building
To construct the amyloid ﬁbril, in-register parallel intermolecular b-sheet
models were made with 40 starting chains for theC2z form. Each strand in the
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models contains a disorderedN-terminal region (residues 1–9), anN-terminal
b-sheet region (residues 10–24), a turn region (residues 25–29), and a
C-terminal b-sheet region (residues 30–40). In comparison to the original
model of a ﬁbril presented by Tycko et al. (45), we have the C-terminal
b-strand ‘‘ﬂipped’’ in orientation, where the residues packed against the
N-terminal b-strand are even numbered, as determined by the most recent
NMR data (46). Models were built with N- and C-terminal strands without
stagger, but interdigitation of structures into staggered structures can be seen
in equilibrated structures at ﬁnite temperature. Once equilibrated, the beads
representing the N- and C-terminal b-sheets interdigitate to form contacts
internal to each subunit of the ﬁbril with a particular value of ‘‘stagger’’(46).
The most recent solid state NMR work has suggested that the stagger is either
STAG(12) or STAG(2) (46), although our models under thermal equili-
bration give STAG(1) (48). Models for different seed sizes (4,6,8,10,12,14,
16,18,20)were created by retaining the inner-most chains from the equilibrated
40-chain starting structures to ensure that edge effects (loss of perfect ﬁbrillar
order of the exterior chains) were not incorporated into the seeds.
Simulation protocol
Weuse constant-temperature Langevin dynamics with friction parameter z¼
0.05. Bond lengths are held rigid by using the RATTLE algorithm (57). All
simulations are carried out in reduced units,withmassm, energy eH, and kB all
set equal to unity. The 40-chain C2z ﬁbril models were equilibrated with
Langevin dynamics at a temperature of 0.45 for 1500t (300,000 steps). This
procedure was repeated between 50 (Arctic and Flemish) and 100 (WT and
Dutch) times so that the stochastic dynamics generated 50 or 100 equilibrated
starting structures of a 40-chain ﬁbril seed forC2z; 1–3 simulations of each of
the 50–100 models were run for 5000t (1,000,000 steps) at T* ¼ 0.45 (T 
337K).
The reported protoﬁbril stability data are based on statistics collected
;50–150 independent simulations per chain number. Statistics on the chain
conformation were gathered every 50t (10,000 steps). Structural stability for
each time point was quantiﬁed by two different variants of the x parameter:
x ¼ 1
M
+
Nc
a¼1
+
Nc
b. c
+
N
i
+
N
j
h e jra;i;b;j  r0a;i;b;jj
 
: (1)
The generic x parameter evaluates the sum over bead i on chain a and bead j
on chain b and a and b range over the Nc chains making up the exterior and
neighboring chains on each end, h is the Heaviside step function, e is the
tolerance set to 0.5 distance units (;1.9A˚), ra:i;b:j is the distance between
bead i on chaina and bead j on chain b, r0a:i;b:j is the pair distance in the initial
structure, andM is a normalizing constant counting the total number of pairs.
The two variants of the x parameter involve different ranges of the re-
stricted sum over chains a and b, and beads i and j in Eq. (1). xf measures
b-strand order on an individual protoﬁlament and alignment of the proto-
ﬁlament with the ﬁbril axis, by evaluating i and j over the range from (17–21;
31–35), and over four monomer chains on each end (two independent con-
tributions from each end involving a total of eight chains). Pf measures the
nativeness of an individual protoﬁlament, by evaluating i and j over the range
from (17–35), including both b-strand regions as well as the turn connecting
these regions. BecausePf is isolated to a single protoﬁlament, each protoﬁbril
end has two values of Pf that are binned independently (four independent
contributions involving eight chains total).
Free energy proﬁles
Based on the ensemble composed of the ﬁnal structures of each of the 50
independent trajectories for each sequence and for each oligomer size, n, we
can calculate equilibrium populations of structurally stable and unstable
protoﬁbrils based on population differences measured by either Pf or xf . For
chain lengths and mutant combinations for which the population of either
stable or unstable protoﬁbrils is very small, we run an additional 100 tra-
jectories for a total of 150 trajectories to reduce the error of our population
estimates. The fraction of trajectories corresponding to Pf . 0.7 or xf. 0.7
measures a population,Cn, of n-ordered monomers in a protoﬁbril with intact
end monomers and a well-deﬁned ﬁbril axis. This population is in equilib-
rium with the remaining fraction of trajectories corresponding to a protoﬁbril
with loss of structural order corresponding to Pf, 0.7 or xf, 0.7, and thus
measures the populationCn1.We have chosenPf and xf dividing surfaces of
0.7 based on the best single value of the parameters that divides the high and
low chain number populations. We conﬁrmed the choice of value by visual
examination of structures with a range of Pf and xf values and found the
values to divide ordered and disordered structures accurately.
Based on thermodynamic arguments advanced by Ferrone (28) for
nucleation–polymerization reactions relevant for aggregation kinetics, at
equilibrium we can estimate the change in free energy, DG, per unit mon-
omer as
dDG
dn
¼ kT ln Cn1½ 
Cn½ 
 
; (2)
where n is half the number of monomers, and kT, is the Boltzmann constant
multiplied by the temperature. Integration over all oligomer sizes allows us to
generate a free energy curve based on Cn and Cn1 populations measured in
our model for the different sequences.
RESULTS
We investigate the structural stability of ﬁbril seed models for
the Arctic, Dutch, and Flemish mutants ranging from 2 to 10
dimer cross sections (i.e., 4–20 monomer chains) under the
C2z symmetry form of the agitated ﬁbril morphology. Each of
these protoﬁbril sizes are simulated using Langevin dynam-
ics at a constant temperature of T* ¼ 0.45 (T  337K), and
wemonitor the amount of ﬁbril order as a function of time. As
a measure of ﬁbril order, we deﬁne two different structural
similarity parameters (see Methods). The ﬁrst order param-
eter, Pf, measures the structural similarity of the ends of the
protoﬁlament subunits with respect to perfect ﬁbril order.
The second order parameter, xf, measures b-strand order over
the ends of the whole protoﬁbril, and thus is sensitive to
disorder at both the level of the protoﬁlament and the qua-
ternary structure of the protoﬁbril.
Fig. 2 shows the histograms of populations of Pf order for
the ﬁnal structures for 4, 8, and 20 peptide assemblies of the
three FAD mutants with respect to the WT Ab sequence. We
see that ﬁbril structural similarity at the level of a protoﬁla-
ment increases in order of FADmutants: Flemish,Arctic,
WT , Dutch at any size protoﬁlament, regardless of the
number of peptides. Because a higher concentration of pep-
tides in solution should drive the equilibrium toward larger
assemblies, the larger sized protoﬁlaments would be more
likely to be found in solutions at higher concentrations. The
greater disorder by this metric for the Flemish and Arctic
mutant is clearly a consequence of the glycine mutation that
permits greater ﬂexibility of the backbone dihedral angles in
the N-terminal b-sheet region. The population distributions
are largely no different for 8 chains versus 20 chains for the
Arctic sequence, whereas there is a systematic gain of some
structure for the Flemish mutant as concentration increases,
although both are less ﬁbril-like than WT. Fig. 3 shows that
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although the Arctic mutant exhibits disorder in the turn re-
gions, it still retains its b-strand pairings, unlike the Flemish
mutant that loses the attachment of the edge monomer to the
protoﬁbril. By contrast, the Dutch sequence shows structural
enhancements over WT by a primary sequence mutation that
eliminates charge repulsion between peptides on the same
protoﬁlament, so that its populations are more ordered than
WT at any chain assembly size. The enhancement of proto-
ﬁlament order for Dutch exaggerates the twist down the
protoﬁlament axis with respect to WT, as shown in Fig. 4.
The protoﬁlament order trends for the mutant and WT
sequence do not predict the trends in our xf metric that
measures retention of order across the protoﬁbril ends. In Fig.
5 we show the histograms of populations of xf for 4, 8, and 20
peptide assemblies of the three FAD mutants with respect to
theWTAb sequence. The four-chain assemblies are equivalent
FIGURE 2 Population histograms with respect to protoﬁlament order (Pf) for 4, 8, and 20 chains. The histograms emphasize that protoﬁlament order
increases for the FAD mutants as Flemish (red) , Arctic (green) , WT (black) , Dutch (blue), at any oligomer size.
FIGURE 3 Representative protoﬁbril
structure of the Arctic and Flemish
mutants. Although both FAD mutants
show disorder in the turn region, the
Arctic mutant (green) retains much
better b-strand structure over the whole
cross section at the end of the 5000t-
trajectories, whereas the Flemish mu-
tant (red) has almost lost a monomer
after the same amount of time.
Familial Alzheimer’s Mutant Protoﬁbrils 2011
Biophysical Journal 94(6) 2007–2016
among the sequences: no protoﬁbrils are present at such low
concentrations. However, ﬁbril structural similarity at the
level of a protoﬁbril is different among the sequences at eight
chains to yield a different order for FAD mutants: Flemish,
Dutch,WT,Arctic. Note that in Fig. 5, top right, the xf at
20 chains for Flemish mutant at 20 chains has a far lower
population at xf. 0.7, never adopting the level of protoﬁbril
order that is reached by the Arctic, Dutch, andWTmutants at
eight chains.
The position of the glycine mutant results in qualitatively
different behavior in the structural integrity of the protoﬁbril.
The glycine mutation at position 21 is far enough into the
N-terminal b-strand to diminish ﬁbril integrity across the
whole end cross section of b-strands. By contrast, the glycine
mutation at position 22 pushes the disorder nearer to the turn
region, thereby retaining b-strand order over the whole cross
section. In both cases, new but nonspeciﬁc stabilizing inter-
actions between the turn region and the b-strands prevent the
protoﬁlaments from rotating with respect to each other so that
both retain a well-deﬁned protoﬁbril axis (Fig. 3).
Although the protoﬁlament assemblies are better formed
for the Dutch mutant, the agitated ﬁbril morphology is not a
viable reference state for ordered protoﬁbril structure (Fig. 5,
aqua). In fact, a new polymorph (comprising 50% of the
population of the 16-, 18-, and 20-chain protoﬁbril, and
;40% for 14-chain, 35% for 12-chain, and 20% for 10-chain)
is seen in which the protoﬁlaments show a shift in register of
b-strand alignment at the interface (Fig. 6). Even when this
new polymorph serves as an additional reference state for ﬁ-
bril order (Fig. 5, blue), there is still some disorder for the
Dutch mutant when it is compared with WT at the same
number of chains, as seen by the shallower negative slope for
Dutch, which is due to more rotational freedom of one pro-
toﬁlament with respect to another.
DISCUSSION
The kinetics of preﬁbrillar Arctic and WT Ab peptides have
been quantiﬁed by chromatographic methods that measure
rates of appearance and disappearance of monomer and/or
Ab oligomer assemblies based on their mass (9), with no
information as to their structural characteristics. A more
structurally informative kinetic assay is based on Congo Red
or Thioﬂavin T dye-binding ﬂuorescence (49) that measures
the disappearance of monomer into growing ﬁbril assemblies
that have cross b-strand order, whose long-time saturation
indicates the formation of mature ﬁbrils. However, even this
kinetic measurement is not particularly sensitive to the
structural details of the oligomeric assemblies that are accu-
mulating in the measured kinetic proﬁles.
Our examination has shown that substantial differences in
structural ensembles exist between the four different Ab
sequences based on Pf and xf. Both the Pf and xf metrics are
consistent in the formation of good cross b-strand order, so
that kinetic assays based on Congo Red or Thioﬂavin T dye-
binding ﬂuorescence are equally relevant to both of these
reaction coordinates. The only difference between Pf and xf
is that the latter assumes a higher level of structural organi-
zation so that pairs of protoﬁlaments are well-deﬁned with
respect to the ﬁbril axis to adopt the agitated ﬁbril mor-
phology. How do these structural ensembles for the different
mutants connect to the observed differences in their kinetic
rates of ﬁbrillization? We make this connection under the
assumption of a dynamic equilibrium between monomer and
protoﬁbril states, with the equilibrium constant allowing us to
deﬁne a free energy proﬁle as a function of protoﬁbril as-
sembly size (see Methods).
Fig. 7 a plots the free energies as a function of oligomer
size for the WT and familial mutant sequences based on
protoﬁbril order, with xf . 0.7. We ﬁnd that the size of the
critical nucleus shifts dramatically to a smaller number of
monomer cross sections for the Arctic mutant corresponding
to 6–8 chains, and exhibits a greater drive to form protoﬁbrils
with respect to WT given the smaller free energy barrier. For
the Flemish mutant we ﬁnd that the critical nucleus is shifted
to beyond 20 chains analyzed in this study, thereby always
favoring the monomer. The free energy proﬁle for the Dutch
mutant using the agitated ﬁbril morphology relevant for WT
is a poor measure of order into higher order protoﬁlament
assemblies. Even when we add the additional polymorph as
a reference structure, we ﬁnd that the Dutch mutant has
the same critical nucleus size and slightly larger barrier to
protoﬁbril order with respect to WT. Given that the ﬁbrilli-
zation kinetics are faster for Dutch relative to WT, this result
FIGURE 4 Representative protoﬁla-
ment structure of the Dutch mutant
compared with the WT sequence. Al-
ready after only initial equilibration
from the model build, the Dutch mutant
(blue) shows a greater twist of the
intermolecular b-sheet down the proto-
ﬁlaments with respect to WT (black).
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suggests that the Dutch mutant does not favor the higher
order assemblies of protoﬁlament–protoﬁlament organiza-
tion that arise from variations of the agitated protoﬁbril
morphology.
As a measure of lower order assemblies, Fig. 7 b exhibits
the free energies as a function of oligomer size for the WT
and familial mutant sequences based on protoﬁlament order,
with Pf . 0.7. We see that the Dutch mutant shows the
FIGURE 6 Representative protoﬁbril
structure of the Dutch mutant with re-
spect to WT. A comparison of the
Dutch polymorph (blue) with respect
to the agitated ﬁbril morphology (17,
31–33) favored by the WT sequence
(black) at the end of the 5000t-trajec-
tories. The yellow spheres represent
amino acid 33 on each monomer chain,
which shows how it is displaced due
to a register shift of the C-terminal
b-strands at the interface under the
Dutch polymorph.
FIGURE 5 Population histograms with respect to protoﬁbril order (xf) for 4, 8, and 20 chains. Although no protoﬁbrils are present for the four-chain
assemblies for any sequences, the level of protoﬁbril structure is different among the sequences at eight chains to yield the following trend for FAD mutants:
Flemish (red),Dutch (aqua),WT (black),Arctic (green). Even with the addition of the Dutch polymorph as a reference state (blue), there is slightly more
disorder for the Dutch with respect to WT.
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smallest critical nucleus and free energy barrier relative to all
other sequences. The Dutch mutant preference for lower
order assemblies involving only protoﬁlaments that are not
subject to the free energy barrier for ordering and aligning a
two-ﬁlament cross-section ﬁbril (48) may explain its signif-
icantly enhanced ﬁbrillization kinetics using dye-binding
assays of cross b-sheet structure. Alternatively, a higher or-
der assembly of a substantially different polymorph other
than the agitated ﬁbril morphology may be relevant for its
ﬁbrillization mechanism. By this measure the Arctic mutant
shows a ﬂat free energy curve indicating that its structural
stability arises primarily from protoﬁlament-protoﬁlament
alignments to deﬁne a ﬁbril axis, and that the agitated ﬁbril
assembly is a good model for this mutation. Again the
Flemish mutant is disordered and never exhibits a stable
protoﬁlament regime. This result is similar to that found by all
atom simulations of a Flemish mutation dimer where the
A21Gmutation destabilized the dimeric assembly (34). In this
study, we show that this destabilization is present in ordered
oligomers larger than dimers and that this local disorder leads
to protoﬁbrillar instability. Given the nature of the A21G mu-
tation that so strongly favors the monomer over ordered cross
b-sheet structure, we believe no speciﬁc alternative ordered
protoﬁbril reference state exists for the Flemish mutant.
CONCLUSIONS
We have used a coarse-grained protein model to measure
structural stability trends of Ab protoﬁbril assemblies for WT
as well as for Arctic (E22G), Dutch (E22Q), and Flemish
(A21G) mutant sequences. We ﬁnd that although the single
point mutations are localized in the same region of the Ab
peptide, their structural ensembles are quite distinct, and the
mutations can disrupt organization at the level of protoﬁlament
up through protoﬁbril order. By measuring the equilibrium
populations of monomer 5 protoﬁlament or monomer 5
protoﬁbril as a function of protoﬁbril size, we determine free
energy proﬁles that are consistent with the attainment of cross
b-sheet structure measured by dye-binding assays, while pro-
viding better structural information on which to develop new
hypotheses for experimental investigation.
We ﬁnd that although both the Arctic and Flemish se-
quences promote greater disorder of the b-turn region of the
Ab peptide, the difference in sequence position of the glycine
mutation radically alters ﬁbril order stability. The glycine
mutation at position 21 in the Flemish mutant disrupts the
exterior N-terminal strand regions, thereby degrading order
throughout each protoﬁlament and at the interface between
protoﬁlaments. Regardless of the detection method (Pf versus
xf) for cross b-sheet structure, the dynamic equilibrium
strongly favors the monomeric peptide for the Flemish mu-
tant. The greater resistance of the Flemish mutant to order
into ﬁbril assemblies of any size suggests that it is capable of
both greater fragmentation into smaller oligomers that can
readily diffuse, whereas at the same time possibly promoting
amorphous aggregation to yield large plaques by recruiting
other proteins and extracellular constituents into its more
unstructured Ab aggregates. Our results suggest it would
have no deﬁnitive single ﬁbril morphology reference state.
By contrast, the glycine mutation at position 22 is enough
removed from the N-terminal strands that they retain their
protoﬁlament order, although it does increase the ﬂexibility
in the turn region of the Abmonomer. The more ﬂexible loop
can form new contacts that stabilize the ﬁbril at the interface
so that little rotation between the protoﬁlaments is exhibited
beyond six chains. It seems likely, however, that although the
FIGURE 7 (a) Free energy proﬁle for free monomer and protoﬁbril (xf)
equilibrium for the WT and FAD mutants. The free energy shows a
maximum corresponding to the critical nucleus size of 6 chains for Arctic
(green), 10 chains for WT (black), and no preferred order for either Dutch
(aqua) or Flemish (red) mutants. The constant, negative slope beyond the
critical nucleus is indicative of reaching a stable ﬁbril regime in which
the equilibrium shifts decidedly away from the monomer form. When the
alternative polymorph for the Dutch mutant (Fig. 6) is added as a reference
for ﬁbril order (blue), there is now a critical nucleus of 10 chains for the
E22Q mutant but with a larger free energy barrier and shallow slope
indicating a slower approach to protoﬁbril order for the Dutch mutant. (b)
Free energy proﬁle for free monomer and protoﬁlament (Pf) equilibrium for
the WT and FAD mutants. The free energy shows a maximum correspond-
ing to the critical nucleus size of 6 chains for Dutch (blue), 6–8 chains for
WT (black), and no preferred order for either Arctic (green) or Flemish (red)
mutants. The constant, negative slope beyond the critical nucleus is indic-
ative of reaching a stable regime in which the equilibrium favors the
protoﬁlament form, which is more strongly evident for Dutch over WT.
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critical barrier is rapidly reached at lower concentrations than
WT, the new stabilizing contacts could slow the addition of
monomer beyond that point, i.e., that there is a separation
between rapid attainment of small oligomers that do not
translate into more rapid rates of ﬁbrillization into large as-
semblies. This would be consistent with chromatography
methods that measure more rapid disappearance of monomer
into oligomer formations for Arctic relative to WT, but ﬁnd
little difference in rates of forming ﬁbrils from these oligomer
states (9).
The Dutch mutant shows an increase in protoﬁlament or-
der, i.e., better alignment of b-strands on the N-terminal
(amino acids 17–21) and C-terminal b-strand regions (amino
acids 31–35) and little disorder in the turn region. However,
structural rearrangements in the monomer creates a new twist
angle in the protoﬁlament that does not allow the protoﬁla-
ments to align along the ﬁbril axis consistent with the agitated
ﬁbril structure found for the WT sequence. In fact, rear-
rangement between the protoﬁlaments results in a new poly-
morph of the Dutch protoﬁbril that is populated substantially.
The enhanced ﬁbrillization kinetics measured by dye-binding
assays of cross b-sheet structure for the Dutch mutant may
stem in part from its possible preference for lower order as-
semblies involving only protoﬁlaments. Alternatively, a higher
order assembly of protoﬁlaments into a different polymorph
other than the agitated ﬁbril morphologymay be relevant for its
ﬁbrillization mechanism.
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